The Selenium and Vitamin E Cancer Prevention Trial (SELECT) was started to evaluate the role of vitamin E and selenium supplementation in preventing prostate cancer.[39] This prospective, randomized, double-blind, placebo-controlled prevention trial involved healthy men with a normal digital rectal examination and a serum PSA level below 4 ng/ml. Here, KLK3 is linked to cancer.